GI & Endoscopy

The FDA approved Defitelio to treat severe hepatic veno-occlusive disease, a rare liver condition.

AmSurg and Stop Colon Cancer Now sponsored Fight Colorectal Cancer's One Million Strong Showcase in Nashville on April 1.

Researchers at University of Calgary's Cumming School of Medicine in Alberta, Canada, are working to answer what diets are beneficial to people living with inflammatory bowel disease, according to UToday.

A study published in The American Journal of Gastroenterology found black patients may do better when they're treated at U.S. hospitals with more racially diverse populations, as reported by The Huffington Post.

Takeda Pharmaceuticals is entering a multi-year research partnership with the University of Chicago and the Icahn School of Medicine at Mount Sinai in New York City to study inflammatory bowel disease.

The Federal Trade Commission is asking for more information from Pfizer and Allergan regarding their pending merger deal, according to a Wall Street Journal report.

Medtronic's PillCam COLON 2 capsule was cleared by the FDA for an expanded indication.

Brighter Health Network and Medspira are partnering to further market, distribute and service Medspira's mcompass anorectal manometry system.

Smart Clinic, a new mHealth company founded by gastroenterologist Paul J. Berggreen, MD, has been selected as a winner in the fall 2015 round of the Arizona Innovation Challenge.

Ronnie Fass, MD, is the director of gastroenterology and hepatology as well as head of the Esophageal & Swallowing Center at MetroHealth in Cleveland. His clinical expertise is in gastroenterology, digestive disorders, gastrointestinal motility disorders, gastroesophageal reflux disease and esophageal…